AS601245 ≥95%, Moligand™

Supplier: ALADDIN SCIENTIFIC CORPORATION

Synonyms: (Z)-2-(benzo[d]thiazol-2-yl)-2-(2-((2-(pyridin-3-yl)ethyl)imino)-1,2-dihydropyrimidin-4-yl)acetonitrile, (2Z)-2-(3H-1,3-Benzothiazol-2-ylidene)-2-[2-(2-pyridin-3-ylethylamino)pyrimidin-4-yl]acetonitrile, SAPK Inhibitor V, 2-(Benzo[d]thiazol-2-yl)-2-(2-((2-(pyridin-3-yl)ethyl)amino)pyrimidin-4-yl)acetonitrile, 1,3-Benzothiazol-2-yl-(2-((2-(3-pyridinyl)ethyl)amino)-4-pyrimidinyl)acetonitrile

A275935-5MG A275935-100MG A275935-10MG A275935-1MG A275935-25MG A275935-50MG
ALA275935-5MGEA 112.01 USD
ALA275935-5MG ALA275935100MG ALA275935-10MG ALA275935-1MG ALA275935-25MG ALA275935-50MG
AS601245 ≥95%, Moligand™
AS601245

Store at -20°C. Store under desiccating conditions. The product can be stored for up to 12 months.Product Introduction:A cell-permeable pyrimidinyl compound that displays anti-inflammatory properties. Acts as a potent, reversible, and ATP-competitive inhibitor of c-Jun N-terminal kinase (JNK, IC50 = 150, 220, and 70 nM for hJNK1, hJNK2, and hJNK3, respectively) with a 10- to 100-fold greater selectivity over a panel of 25 other commonly studied kinases (IC50 typically in the range of 1-10 µM or no effect at 10 µM). Its in vivo efficacy has been demonstrated in gerbils, mice, and rats via oral, i.v., or i.p. administration. Biochemical mechanism:Cell permeable: yesProduct competes with ATP.Primary TargethJNK 1, hJNK 2, hJNK 3Reversible: yesTarget IC50: 150, 220, and 70 nM for hJNK1, hJNK2, and hJNK3, respectively

Formula: C₂₀H₁₆N₆S
MW: 372.45 g/mol
Storage Temperature: Freezer
MDL Number: MFCD07772196
CAS Number: 345987-15-7
https://digitalassets.avantorsciences.com/adaptivemedia/rendition?id=8ecd01004b2dea058a65edecd322b177f399fa1a&vid=8ecd01004b2dea058a65edecd322b177f399fa1a&prid=web&clid=SAPDAM

Order Now

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR